{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T06:41:55Z","timestamp":1722753715441},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T00:00:00Z","timestamp":1374796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11845-013-0990-2","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:38Z","timestamp":1374710438000},"page":"199-206","source":"Crossref","is-referenced-by-count":3,"title":["Familial breast cancer genetic testing in the West of Ireland"],"prefix":"10.1007","volume":"183","author":[{"given":"T. P.","family":"McVeigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Kerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,26]]},"reference":[{"issue":"1","key":"990_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/bcr6","volume":"1","author":"DF Easton","year":"1999","unstructured":"Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1(1):14\u201317","journal-title":"Breast Cancer Res"},{"issue":"10","key":"990_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA 1 and BRCA 2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301\u20131308","journal-title":"Br J Cancer"},{"issue":"1","key":"990_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","volume":"86","author":"AC Antoniou","year":"2002","unstructured":"Antoniou AC, Pharoah PDP, McMullan G et al (2002) A comprehensive model for familial breast cancer incorporating BRCA 1, BRCA 2 and other genes. Br J Cancer 86(1):76\u201383","journal-title":"Br J Cancer"},{"issue":"6","key":"990_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgq069","volume":"31","author":"PJ O\u2019Donovan","year":"2010","unstructured":"O\u2019Donovan PJ, Livingston DM (2010) BRCA 1 and BRCA 2: breast\/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 31(6):961\u2013967","journal-title":"Carcinogenesis"},{"issue":"3","key":"990_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R (2010) Founder BRCA 1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397\u2013412","journal-title":"EPMA J"},{"issue":"1","key":"990_CR6","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL et al (2006) Analysis of cancer risk and BRCA 1 and BRCA 2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12","journal-title":"Breast Cancer Res"},{"issue":"23","key":"990_CR7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DEC et al (2006) Population BRCA 1 and BRCA 2 mutation frequencies and cancer penetrance: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694\u20131706","journal-title":"J Natl Cancer Inst"},{"issue":"8899","key":"990_CR8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al (1994) Risks of cancer in BRCA 1-mutation carriers. Breast cancer linkage consortium. Lancet 343(8899):692\u2013695","journal-title":"Lancet"},{"issue":"3","key":"990_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA 2 genes in breast cancer families. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"5","key":"990_CR10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA 1 or BRCA 2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"3","key":"990_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<284::AID-IJC2>3.0.CO;2-W","volume":"65","author":"DF Easton","year":"1996","unstructured":"Easton DF, Matthews FE, Ford D et al (1996) Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 65(3):284\u2013294","journal-title":"Int J Cancer"},{"issue":"3","key":"990_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X","volume":"65","author":"J Peto","year":"1996","unstructured":"Peto J, Easton DF, Matthews FE et al (1996) Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 65(3):275\u2013283","journal-title":"Int J Cancer"},{"issue":"5","key":"990_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA 1 or BRCA 2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"2","key":"990_CR14","first-page":"60","volume":"7","author":"B Friedenson","year":"2005","unstructured":"Friedenson B (2005) BRCA 1 and BRCA 2 pathways and the risk of cancers other than breast or ovarian. Med Gen Med 7(2):60","journal-title":"Med Gen Med"},{"issue":"4","key":"990_CR15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/424697","volume":"75","author":"B McEvoy","year":"2004","unstructured":"McEvoy B, Richards M, Forster P et al (2004) The longue dure\u00e9 of genetic ancestry: multiple genetic marker systems and celtic origins on the Atlantic facade of Europe. Am J Hum Genet 75(4):693\u2013702","journal-title":"Am J Hum Genet"},{"issue":"9","key":"990_CR16","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1073\/pnas.071036898","volume":"98","author":"JF Wilson","year":"2001","unstructured":"Wilson JF, Weiss DA, Richards M et al (2001) Genetic evidence for different male and female roles during cultural transitions in the British Isles. Proc Natl Acad Sci USA 98(9):5078\u20135083","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6776","key":"990_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/35006158","volume":"404","author":"EW Hill","year":"2000","unstructured":"Hill EW, Jobling MA, Bradley DG (2000) Y-chromosome variation and Irish origins. Nature 404(6776):351\u2013352","journal-title":"Nature"},{"issue":"2","key":"990_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.ejhg.5201938","volume":"16","author":"CT O\u2019Dushlaine","year":"2008","unstructured":"O\u2019Dushlaine CT, Dolan C, Weale ME et al (2008) An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseases. Eur J Hum Genet 16(2):176\u2013183","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"990_CR19","first-page":"505","volume":"60","author":"D Abeliovich","year":"1997","unstructured":"Abeliovich D, Kaduri L, Lerer I et al (1997) The founder mutations 185delAG and 5382insC in BRCA 1 and 6174delT in BRCA 2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60(3):505\u2013514","journal-title":"Am J Hum Genet"},{"issue":"2","key":"990_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng1096-188","volume":"14","author":"C Oddoux","year":"1996","unstructured":"Oddoux C, Struewing JP, Clayton CM et al (1996) The carrier frequency of the BRCA 2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14(2):188\u2013190","journal-title":"Nat Genet"},{"issue":"20","key":"990_CR21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA 1 and BRCA 2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408","journal-title":"N Engl J Med"},{"key":"990_CR22","unstructured":"WHO (2004) The molecular genetic epidemiology of cystic fibrosis: report of a joint meeting of World Health Organisation; European Cystic Fibrosis Thematic Network; International Cystic Fibrosis (Mucoviscidosis) Association; European Cystic Fibrosis Society"},{"issue":"3","key":"990_CR23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2354.1998.00094.x","volume":"7","author":"A Br\u00e9dart","year":"1998","unstructured":"Br\u00e9dart A, Autier P, Audisio RA et al (1998) Psycho-social aspects of breast cancer susceptibility testing: a literature review. Eur J Cancer Care 7(3):174\u2013180","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"990_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cancergencyto.2005.07.011","volume":"165","author":"HT Lynch","year":"2006","unstructured":"Lynch HT, Snyder C, Lynch JF et al (2006) Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 165(2):91\u201397","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"990_CR25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10897-009-9232-1","volume":"18","author":"HA Douglas","year":"2009","unstructured":"Douglas HA, Hamilton RJ, Grubs RE (2009) The effect of BRCA gene testing on family relationships: a thematic analysis of qualitative interviews. J Genet Couns 18(5):418\u2013435","journal-title":"J Genet Couns"},{"issue":"27","key":"990_CR26","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","volume":"28","author":"JS Kwon","year":"2010","unstructured":"Kwon JS, Gutierrez-Barrera AM, Young D et al (2010) Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol 28(27):4214\u20134220","journal-title":"J Clin Oncol"},{"issue":"SUPPL. 6","key":"990_CR27","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/annonc\/mdr373","volume":"22","author":"J Balma\u00f1a","year":"2011","unstructured":"Balma\u00f1a J, D\u00edez O, Rubio IT et al (2011) BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol 22(SUPPL. 6):vi31\u2013vi34","journal-title":"Ann Oncol"},{"issue":"5","key":"990_CR28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","volume":"28","author":"ME Robson","year":"2010","unstructured":"Robson ME, Storm CD, Weitzel J et al (2010) American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28(5):893\u2013901","journal-title":"J Clin Oncol"},{"issue":"6","key":"990_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","volume":"41","author":"DGR Evans","year":"2004","unstructured":"Evans DGR, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA 1\/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474\u2013480","journal-title":"J Med Genet"},{"key":"990_CR30","unstructured":"NICE, NICE guideline CG041 (2006) Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. NICE, London"},{"issue":"1","key":"990_CR31","first-page":"33","volume":"79","author":"T McDevitt","year":"2010","unstructured":"McDevitt T, Higgins M, Crowley A et al (2010) Spectrum and incidence of BRCA 1 and BRCA 2 mutations in the Republic of Ireland\u2014an audit (abstract). Ulster Med J 79(1):33\u201342","journal-title":"Ulster Med J"},{"issue":"7311","key":"990_CR32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"DM Altshuler","year":"2010","unstructured":"Altshuler DM, Gibbs RA, Peltonen L et al (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467(7311):52\u201358","journal-title":"Nature"},{"key":"990_CR33","unstructured":"National Human Genome Research Institute, BRCA1 Mutation Database (2011) Available from: http:\/\/research.nhgri.nih.gov\/projects\/bic\/index.shtml"},{"issue":"2","key":"990_CR34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-010-0745-y","volume":"124","author":"I Ticha","year":"2010","unstructured":"Ticha I, Kleibl Z, Stribrna J et al (2010) Screening for genomic rearrangements in BRCA 1 and BRCA 2 genes in Czech high-risk breast\/ovarian cancer patients: high proportion of population specific alterations in BRCA 1 gene. Breast Cancer Res Treat 124(2):337\u2013347","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"990_CR35","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1158\/0008-5472.CAN-08-0599","volume":"68","author":"MD Palma","year":"2008","unstructured":"Palma MD, Domchek SM, Stopfer J et al (2008) The relative contribution of point mutations and genomic rearrangements in BRCA 1 and BRCA 2 in high-risk breast cancer families. Cancer Res 68(17):7006\u20137014","journal-title":"Cancer Res"},{"key":"990_CR36","unstructured":"Devilee P, Hogervorst F (2002) Summary of published and unpublished BRCA1 mutations in the Netherlands and Belgium. Available from: http:\/\/www.humgen.nl\/lab-devilee\/Lab\/b1nlmuts.htm"},{"issue":"1","key":"990_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/109065704323016003","volume":"8","author":"C Foster","year":"2004","unstructured":"Foster C, Evans DGR, Eeles R et al (2004) Non-uptake of predictive genetic testing for BRCA 1\/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Testing 8(1):23\u201329","journal-title":"Genet Testing"},{"issue":"12","key":"990_CR38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pon.933","volume":"14","author":"B Meiser","year":"2005","unstructured":"Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14(12):1060\u20131074","journal-title":"Psychooncology"},{"key":"990_CR39","first-page":"126","volume":"45","author":"JC Carroll","year":"1999","unstructured":"Carroll JC, Heisey RE, Warner E et al (1999) Hereditary breast cancer: psychosocial issues and family physicians\u2019 role. Can Fam Physician 45:126\u2013132","journal-title":"Can Fam Physician"},{"issue":"12","key":"990_CR40","first-page":"1579","volume":"11","author":"HS Thompson","year":"2002","unstructured":"Thompson HS, Valdimarsdottir HB, Duteau-Buck C et al (2002) Psychosocial predictors of BRCA counselling and testing decisions among urban African-American women. Cancer Epidemiol Biomark Prev 11(12):1579\u20131585","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"990_CR41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/pon.1062","volume":"16","author":"I Oostrom van","year":"2007","unstructured":"van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al (2007) A prospective study of the impact of genetic susceptibility testing for BRCA 1\/2 or HNPCC on family relationships. Psychooncology 16(4):320\u2013328","journal-title":"Psychooncology"},{"issue":"43","key":"990_CR42","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","volume":"25","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898\u20135905","journal-title":"Oncogene"},{"issue":"1","key":"990_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-009-0540-9","volume":"121","author":"NM McInerney","year":"2010","unstructured":"McInerney NM, Miller N, Rowan A et al (2010) Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat 121(1):203\u2013210","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"990_CR44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/gcc.20330","volume":"45","author":"P Smith","year":"2006","unstructured":"Smith P, McGuffog L, Easton DF et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosom Cancer 45(7):646\u2013655","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"990_CR45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PDP Pharoah","year":"2002","unstructured":"Pharoah PDP, Antoniou A, Bobrow M et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33\u201336","journal-title":"Nat Genet"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-0990-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-013-0990-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-0990-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T17:01:48Z","timestamp":1596214908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-013-0990-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,26]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1007\/s11845-013-0990-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,26]]}}}